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Abstract
Background: The radioactive isotope Strontium-90 (90Sr) may be released as a component of fallout from nuclear
accidents, or in the event of a radiological incident such as detonation of an improvised nuclear device, and if
ingested poses a significant health risk to exposed individuals. In order to better understand the response to 90Sr,
using an easily attainable and standard biodosimetry sample fluid, we analyzed the global transcriptomic response
of blood cells in an in vivo model system.
Results: We injected C57BL/6 mice with a solution of 90SrCl2 and followed them over a 30-day period. At days 4,
7, 9, 25 and 30, we collected blood and isolated RNA for microarray analyses. These days corresponded to target
doses in a range from 1–5 Gy. We investigated changes in mRNA levels using microarrays, and changes in specific
microRNA (miRNA) predicted to be involved in the response using qRT-PCR. We identified 8082 differentially
expressed genes in the blood of mice exposed to 90Sr compared with controls. Common biological functions were
affected throughout the study, including apoptosis of B and T lymphocytes, and atrophy of lymphoid organs.
Cellular functions such as RNA degradation and lipid metabolism were also affected during the study. The broad
down regulation of genes observed in our study suggested a potential role for miRNA in gene regulation. We tested
candidate miRNAs, mmu-miR-16, mmu-miR-124, mmu-miR-125 and mmu-mir-21; and found that all were induced at
the earliest time point, day 4.
Conclusions: Our study is the first to report the transcriptomic response of blood cells to the internal emitter 90Sr
in mouse and a possible role for microRNA in gene regulation after 90Sr exposure. The most dramatic effect was
observed on gene expression related to B-cell development and RNA maintenance. These functions were affected by
genes that were down regulated throughout the study, suggesting severely compromised antigen response, which
may be a result of the deposition of the radioisotope proximal to the hematopoietic compartment in bone.
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Background
The field of radiation biodosimetry seeks to identify the
best and most practical methods for detecting exposure to
radiation; and estimating dose and the potential health
risk to an exposed individual. Gene expression approaches
are being developed to enhance the ability to establish
exposure doses [1–6] and suggest treatment modalities
appropriate to the time and dose received. However most
of this data has been collected, and models built, using
exposure to gamma radiation. There is very little informa-
tion regarding how exposures from internal emitters could
affect dose estimates from large-scale radiation biodosime-
try approaches. This is of concern, as in most large-scale
radiological scenarios significant exposure to inhaled or
ingested radionuclides would be expected [7–10]; and
these could alter the medical prognosis relative to acute
external exposures. Strontium-90, decays by beta emission
to Yttrium. Because neither radionuclide emits photon ra-
diation they are considered to be pure beta emitters.
Strontium is a bone-seeker, as is Yttrium, and is deposited
mainly in bone. Because of the beta emissions and the
radionuclide deposition in bone, most of the committed
* Correspondence: saa2108@cumc.columbia.edu
1Center for Radiological Research, Columbia University Medical Center,
VC11-215, 630 West 168th Street, New York, NY 10032, USA
Full list of author information is available at the end of the article
© 2015 Ghandhi et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Ghandhi et al. BMC Genomics  (2015) 16:586 
DOI 10.1186/s12864-015-1774-z
dose is delivered in skeleton tissue and bone marrow.
With a half-life of 29 years and the shorter penetration
range of beta decay, intake of 90Sr would be expected to
result in long-term exposure spanning the lifetime of an
individual [11–13].
After the Chernobyl accident, 90Sr was found to con-
taminate food and soil and was also internally deposited
in people exposed to fallout [8, 11, 14]. People living
along the Techa River in Russia were also exposed to
90Sr as well as other radionuclides that were dumped
into the river over an extended period during the Cold
War. Individuals exposed to a mean average dose of
100-200 mGy/year during the years of maximum
exposure (1950–56) were found to show inhibition of
hematopoiesis [15], and ongoing epidemiological stud-
ies have shown excess relative risks for both leukemia
[16] and solid cancers in this population [17].
Cancer incidence has also been studied in mice ex-
posed to 90Sr as an internal emitter, and no tumors
were observed below a cumulative average bone dose of
18 Gy [18], suggesting that structural and cellular
effects on bone and hematopoietic functions may be
the highest risks from internal contamination by 90Sr in
mice [19–22]. Other mouse studies have reported 90Sr
effects including altered gene expression and cellular
changes in bone cells [20, 22, 23]. These studies ex-
plored the effects of strontium ingestion, and therefore
chronic exposure, in BALB/c mice, with a maximum dose
of 10 mGy at the end of a 20-week study; and it was found
that these doses affected bone morphogenesis, but not
hematopoiesis.
The present study was designed to investigate gene
expression in peripheral blood, following exposure of
C57BL/6 mice to internal radioactive strontium with a
delivered dose in the range similar to that used success-
fully in a previous study with 137Cs [24]. In this latter
study, we have recently shown that the internal emitter
137Cs, injected as a soluble salt giving total body expos-
ure, can alter gene expression in mammalian blood,
affecting different biological processes across the course
of a 30-day study [24]. In the 90Sr study, we again used
injection as the mode of delivery, in order to maintain
consistent doses in replicates over the 30-day study.
We have shown that 90Sr injection into C57BL/6 mice
results in changes in transcriptomic profiles of blood
cells. Thousands of genes were affected, most of which
were down-regulated after exposure to the radio-
nuclide, with microRNA possibly playing a role in the
coordinate down Typical radiation response genes were
also induced at several times. Our study represents a first
step towards identifying the gene expression response of
blood to 90Sr. This is of importance in the development of
a blood-based gene expression signature of 90Sr to deter-
mine its contribution to the total dose received.
Methods
Animals and irradiation
All animal experiments were conducted in accordance
with applicable federal and state guidelines and were
approved by the Institutional Animal Care and Use
Committee (IACUC) of the Lovelace Biomedical and
Environmental Research Institute (LBERI) and the
IACUC of Columbia University (approval number
AC-AAAG4356). C57BL/6 mice (approximately 10-12
weeks old, 25-30 g) were received from Charles River
Laboratories (Frederick, MD) and were quarantined
for 14 days prior to group assignment by body weight
stratification for randomization into the study.
Animals were administered 90Sr intravenously by tail
vein injection with 200 ± 0.3 kBq 85/90SrCl2 solution in a
volume of 0.05 mL. Strontium-85 (85Sr) was used as a
tracer for the purpose of whole body activity measure-
ment. Strontium-85 comprised approximately 1 % of the
final formulation activity. Although the addition of Sr-85
contributed gamma rays to the emitted radiation from
Sr-90/Y-90, the photons added less than 0.01 % to the
absorbed radiation dose to bone and bone marrow. The
vehicle saline solution was delivered to the control
group. Measurements obtained from the animals and
tissue samples were compared to the calibration curves
of 85/90Sr to determine the amount of 90Sr present. Cali-
bration curves were generated using known amounts of
Sr isotopes, which were placed into phantoms with
geometry consistent with that of the mouse. Phantoms
were analyzed in the same manner as for mice and tissue
samples. The limit of detection for this radio-analytical
method was 40 Bq. After dose administration, mice were
housed individually in micro-isolator cages with lead
shielding used to minimize cross-irradiation from adja-
cent mice. All animals had unlimited access to Teklad
Certified Global Rodent Diet 2016 (Harlan Teklad,
Madison, WI) and to water except during dose adminis-
tration and whole-body in vivo counting. No adverse
effects were noted on the animals, based on clinical
observation during the course of the study.
The animals were divided into five radiation dose
groups, 8 animals per group. The committed radiation
doses were in a range from 1 to 5 Gy. In order to receive
those committed doses, the animals were sacrificed at
days 4, 7, 9, 25 and 30 after 90Sr intravenous administra-
tion. On scheduled necropsy days, animals were euthan-
atized by intraperitoneal (IP) injection of Euthasol
(>150 mg/kg [390 mg/mL pentobarbital and 50 mg/mL
phenytoin in sterile saline]) and weighed. Whole blood
was collected by cardiac puncture in a sterile hood; a full
necropsy was conducted and liver, spleen, kidneys, lungs,
muscles (right and left quadriceps), GI tract (upper and
lower), gonads/reproductive tract, femurs, and any soft
tissue remains were collected. The brain and eyes were
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removed from the skull and combined with the soft
tissue remains.
Biokinetics and dosimetry of 90Sr in mice
Animals were radioassayed for 90Sr whole-body content
using the LBERI in vivo photon counting system, consist-
ing of dual 5″ diameter Phoswich (dual NaI (Tl) – CsI
(Tl) detector and associated pulse height analysis electron-
ics). This in vivo detection system was adapted from a
scintillation detector system originally designed for meas-
uring low-energy photons in vivo in human subjects and
experimental animals [25]. Animals were placed in small
containers, with breathing holes, and measured to de-
termine the amount of radioactivity present in each
animal daily on days 0-7, then on days 9, 11, 15, 16, 20,
23, 25, 27, and 30 after 90Sr administration (until the
time of necropsy). The measurement system was
calibrated for different geometries; phantoms represent-
ing the animal body and samples were developed using
a 85/90Sr NIST-traceable standard solution. Calibration
was performed each day prior to the measurement. The
animals and samples were measured for 3 min. The
90Sr whole body retention profile was derived from
whole body 90Sr measurements. The whole-body reten-
tion data from each mouse were fitted individually to
negative exponential functions. The average whole body
retention equation was determined to be:
R tð Þ ¼ 52:1e−2:0t þ 20:7e−0:13t þ 27:2e−0:005t ð1Þ
Where R(t) represents the whole-body content at time
(t), expressed as percentage of the injected 90Sr activity;
and t is in days. The respective biological half times were
0.3 days, 5.3 days, and 139 days.
In order to calculate the committed absorbed dose to
skeleton, the dose coefficient (Gy.Bq−1 of administered
activity) was derived using Eq. 2. The comparison between
the whole-body activity and the 90Sr content in skeleton at
sacrifice time shows that about 95 % of the whole-body
activity was located in skeleton for all time periods. So the
retention parameters of Eq. 1 were used to calculate the
total number of nuclear transformations (Bq s) in skeleton
for each time period of the study. The S value (Gy/Bq s)
used in Eq. 2 was derived specifically for young adult mice
and rats by Stabin et al. [26].
The committed absorbed doses to the skeleton for each
animal was calculated by multiplying the dose coefficient
(Gy Bq−1) related to the specific sacrifice time for each
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Where Ã(S) is the time-integrated activity (Bq s), equal
to the total number of nuclear transformations in the
source region (skeleton); S (rT← rS, t), in Gy per Bq s, is
the S value from rS to rT of
90Sr + 90Y, where the S value
for a given source (rS) -target (rT) pair is the mean
absorbed dose to the target organ per 90Sr + 90Y total
number of nuclear transformations in the source region.
The current study delivered whole body absorbed
doses to the animals of approximately 1.2, 1.8, 2.1, 4.8
and 5.3 Gy. All animals were injected with the same
activity of 90Sr, and the euthanasia time points post 90Sr
administration were selected to result in the desired
range of whole-body doses to the mice.
Since most soft tissues contained Sr-90 concentra-
tions that were < 1 % those measured in bone, it was
assumed that all material in the whole body was found
in bone. This was essentially the case after 1 day. In
addition, since all animals were consistent in their
whole-body counts, and there were no outliers, all dose
calculations were conducted from an initial whole body
burden and using the same average elimination curve.
Animals in the day 4 group received an average dose of
1.2 ± 0.1 Gy, the day 7 group received an average dose
of 1.8 ± 0.1 Gy, the day 9 group received an average
dose of 2.1 ± 0.3 Gy, the day 25 group received an aver-
age dose of 4.8 ± 0.4 Gy, and the day 30 group received
an average dose of 5.3 ± 0.7 Gy (Table 1).
Microarrays and analysis
All blood samples were collected by cardiac puncture in a
sterile hood. For each animal ~0.4 mL of blood was
collected without anti-coagulant and placed directly into
2 mL of PAXgene Blood RNA stabilization and lysis solu-
tion (PreAnalytix GmBH, catalog#762165), mixed thor-
oughly and shipped at 4 °C in temperature-stabilized
containers. Blood smears were made at the time of blood
collection and manually counted, there were no significant
changes between blood cell counts of control and irradi-
ated mice at any time (p-value >0.05 for all pairs;
Additional file 1). The blood samples in PAXgene solution
were stored for a further 24 h at 4 °C, and then incubated
at room temperature for a minimum of 2 h before

















4 1.2 0.30 3957 3580 (91 %) 56
7 1.8 0.20 3023 2633 (87 %) 68
9 2.1 0.15 3584 3122 (87 %) 56
25 4.8 0.17 3478 2683 (77 %) 74
30 5.3 0.10 5768 4431 (77 %) NA
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proceeding with RNA isolation. RNA was purified follow-
ing the PAXgene Blood RNA kit recommended protocol
with on-column DNaseI treatment. Globin transcripts
were reduced using the Ambion GLOBINclear-Mouse/
Rat kit (Life Technologies, Grand Island, NY, catalog#
AM1981). RNA yields were quantified using the Nano-
Drop ND1000 Spectrophotometer (Thermo Scientific)
and RNA quality was checked using the 2100 Bioana-
lyzer (Agilent Technologies). RNA used for microarray
hybridization had an average RNA Integrity Number
of 8.2.
Cyanine-3 (Cy3) labeled cRNA was prepared with the
One-Color Low Input Quick Amp Labeling Kit (Agilent
Technologies) according to the manufacturer’s instruc-
tions. Dye incorporation and cRNA yield were checked
with the NanoDrop ND1000 Spectrophotometer; 1.6 μg
of cRNA, >9 pmol Cy3 per μg cRNA was fragmented and
hybridized (17 h with rotation at 65 °C) to Agilent Whole
Mouse Genome Microarrays 4X44K v2 (G4846A), and
then washed using the Gene Expression Hybridization Kit
and GE Wash Buffers as recommended by Agilent. Slides
were then scanned with the Agilent DNA Microarray
Scanner (G2505B), and the images were analyzed (Agilent
Feature Extraction Software ver. 10.7) with default param-
eters for background correction and flagging non-uniform
features.
Background-corrected hybridization intensities were
imported into BRB-ArrayTools, Version 4.2.1 [27] log2-
transformed and median normalized. Non-uniform out-
liers or features not significantly above background
intensity in 25 % or more of the hybridizations were
filtered out. A further filter requiring a minimum 1.5
fold change in at least 20 % of the hybridizations was
then applied, probes were averaged to one probe per
gene and duplicate genes were reduced by selecting the
one with maximum signal intensity, yielding a final set
of 14,208 features that were used for subsequent ana-
lyses. The microarray data is available through the
Gene Expression Omnibus with accession number
GSE64775.
RNA from six individual mice for each time point and
condition (with the exception of day 4 samples, for
which only four replicates were available) were hybrid-
ized. Class comparisons were conducted using BRB-
Array Tools to identify genes that were differentially
expressed between controls and 90Sr-exposed animals at
each of the five sacrifice times using a random-variance
t-test [28]. Genes with p-values less than 0.001 and an
additional fold change cut off of ±2 were considered sta-
tistically significant. The false discovery rate (FDR) was
estimated for each gene using the method of Benjamini
and Hochberg [29], to control for false positives. All
genes used in this analysis had a false discovery rate of
<0.002.
Quantitative PCR of mRNA and microRNA
The High-Capacity cDNA Archive Kit (Life Technologies,
Foster City, CA) was used to prepare cDNA from total
RNA. Quantitative real-time RT-PCR (qRT-PCR) was
performed for selected genes using Taqman assays (Life
Technologies) to confirm microarray experiment findings
for the selected genes. Assays for genes were as follows:
Mt2 (assay ID: Mm04207591_g1); Unc93b1 (assay ID:
Mm00457643_m1); Cdkn1a (assay ID: Mm01303209_
m1); Ccng1 (assay ID: Mm00438084_m1); Ddb2 (assay ID:
Mm1333909_m1) and Bbc3 (assay ID: Mm00519268_m1).
In gene expression validation studies, 20 ng cDNA was
used as input for replicate reactions. Quantitative real time
PCR reactions were performed with the ABI 7900 Real
Time PCR System using Universal PCR Master Mix (Life
Technologies), with initial activation at 50 °C for 120 s
and 95 °C for 10 min, followed by 40 cycles of 95 °C for
15 s and 60 °C for 60 s. Relative fold-induction was calcu-
lated by the ΔΔCT method, using SDS version 2.3 (Ther-
mofisher). Data were normalized to Actb gene expression
levels, which were found to be stably expressed across all
samples.
Specific miRNA were also measured using Taqman
miRNA assays (Life Technologies). RNA of four miRNA
species were measured: mmu-miR-16 (assay ID: 000391);
mmu-miR-124 (assay ID: 001182); mmu-miR-125 (assay
ID: 000449) and mmu-miR-210 (assay ID: 000512), fol-
lowing the recommended protocol from Life Technolo-
gies. Relative fold-induction was calculated by the ΔΔCT
method, using SDS version 2.3 (Thermofisher). Data
were normalized to U6snRNA (Life Technologies, cata-
log number 4427975) expression levels.
All qRT-PCR results are shown as average of biological
replicate samples using unpaired analyses and p-values
were computed (using two-sample t-test assuming un-
equal variances) for differences between irradiated and
control samples at every time point measured. All fold
changes >2 and <0.5 were significant (p-value <0.05)
with the exception of Cdkn1a at day 4 (p-value > 0.05).
Gene ontology and pathway analysis
Lists of genes significantly over- or under-expressed re-
lative to controls were imported separately into the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) ver 6.7 to identify enriched biological
themes and gene ontology (GO) terms using the func-
tional annotation tool [30]. Benjamini corrected p values
<0.05 were considered significant.
The significantly differentially expressed gene lists from
each sacrifice time, along with their relative expression
levels, were also imported into Ingenuity Pathways Ana-
lysis (IPA) (Ingenuity® Systems, http://www.ingenuity.com)
and analyzed with the IPA Core Analysis Tool. IPA uses
curated information on the published relationships
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between gene products to predict networks and associa-
tions between genes in a list. The upstream regulator ana-
lysis specifically uses information about the relationship
between the activity of potential upstream regulatory fac-
tors (transcription factors, cytokines, receptor mediated
nuclear factors and microRNA were chosen for these ana-
lyses) and the expression changes of the measured genes
to make predictions on the regulatory status of the up-
stream molecule. IPA generates a z-score for each factor
in the upstream regulator analysis and for prediction of
activation or inhibition state of biological functions. The
IPA default cutoff of z > 2 was used to predict activation
and z < −2 to predict inhibition.
Results
Animals in this study were weighed before necropsy on
days 4, 7, 9, 25 and 30 and no significant differences were
observed in weight between control and 90Sr-injected
groups. Dose rates in this study were relatively low,
ranging from an average of 0.3 Gy/day from injection to
the earliest time of necropsy, day 4, to an average of
0.1 Gy/day between days 25 and 30, representing a change
by a factor of 3 across the study time course (Table 1).
The average accrued dose at the 30-day time point was
5.3 Gy (Table 1). The relative retention of 90Sr over the
course of the experiment is shown in Fig. 1a and reflects
the rapid loss of activity that occurred in the first 24 h
after injection, when the amount of 90Sr fell to 52.0 ±
3.3 % of the initial amount, followed by a more gradual
loss of 90Sr through the rest of the study and hence more
stable dose rates. At necropsy, after blood samples were
collected, individual organs and carcass were measured
for 90Sr activity and the skeleton (represented by the right
and left femur) and carcass (containing the rest of the
skeleton) contained most of the radioactive strontium
(Fig. 1b).
Microarray results
At each time point, days 4, 7, 9, 25 and 30, blood was
collected from mice and RNA was isolated. RNA was
processed to cRNA labeled with Cy3 and hybridized to
whole genome mouse arrays using the Agilent platform
and recommended protocols. We used BRB-ArrayTools
[27] to collate the project; and after filtering the data
14,208 genes remained that were used for further ana-
lysis steps. Class comparisons were made between con-
trol and irradiated mouse blood samples at each time
point, and the resulting gene expression changes and
trends are summarized in Table 1. A large number of
genes were changed, with a total of 8082 genes over the
30-day time course (Additional file 2). The number of
differentially expressed genes at the individual time
points and the relative overlap with genes at subsequent
times in the study indicated that although there were
genes that were affected similarly across the time course,
a large proportion of genes were specific to a time/dose,
suggesting that unique biological functions were being
activated or repressed at different times in the study. We
also found that 1184 genes were significantly diffe-
rentially expressed at all 5 time points (Fig. 2a). The ma-
jority of these genes, (1180 out of 1184) were down
regulated throughout the study (Fig. 2b), with corre-
sponding levels in control mice remaining stable over
the 30 days. See Additional file 3 for a list of these genes
and a brief summary of the PANTHER biological pro-
cesses analysis.
A B
Fig. 1 Analysis of 90Sr retention for dose calculation. a Retention of 90Sr over the time course of the study, points are whole-body counts of 90Sr
activity shown as percentage of the injected amount; measured daily on days 0-7, then on days 9, 11, 15, 16, 20, 23, 25, 27, and 30 after injection.
Points are average counts and error bars are SEM of animals measured over the time course. b Amount of 90Sr activity recovered after necropsy
in femur (right and left) and carcass (not de-boned containing the remaining skeletal tissue). The average content on day 4 was 142 nCi, which
decreased to 126 nCi on day 7 and 116 nCi on day 9. Femur content (●) stabilized for the last two collection times. Carcass content (■) on the
day of euthanasia and necropsy was consistent with collected whole-body counts and decreased for the duration of the study. All points are
average and SEM measurements of 90Sr activity measured in necropsied animals on days indicated
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Gene ontology analysis of the 1184 genes common to
all times revealed top pathways affected at the gene ex-
pression level. These were KEGG pathways, mmu04662:
B-cell receptor signaling pathway (19 genes changed,
Bonferroni p-value 6.8 ×10−5), mmu04672: intestinal
immune network for IgA production (13 genes changed,
Bonferroni p-value 7.0 ×10−3); and mmu03018: RNA
degradation (13 genes changed, Bonferroni p-value 2.1
×10−2) and mmu05340: Primary immunodeficiency (10
genes changed, Bonferroni p-value 2.4 ×10−2).
We then analyzed all genes affected at the 5 time
points of this study using the IPA biological functions
tool to assess and compare categories of biological pro-
cesses activated or inhibited in the course of the study,
as predicted from gene expression changes. These are
shown in Fig. 3. The heat map shows the scale of pre-
dicted activation (shades of orange) and inhibition
(shades of blue) states for each biological function across
the 5 times measured in this study. There were many
processes predicted to be significantly affected across all
times in the study, with most showing similar activation
or inhibition across the study. These processes are
sorted by decreasing z-scores and time point, shown in
Fig. 3. There were many processes that were significant
starting at day 4 and then mostly significant at other
time points (group I); in which the top activated pro-
cesses were atrophy of lymphatic systems, apoptosis of B
and T cells, activation of lysosomal storage and auto-
immune disease. Top inhibited processes within this
group affected cell survival, cell viability, infection and
migration of cells. More specifically, the gene expression
changes belonged to potentially inhibited functions cen-
tered on apoptosis of B-cells, cell death of leukocytes
and atrophy of lymph glands. Within group II, processes
emerging as significant on day 7 included activation of
hyperplasia of spleen and inhibition of antiviral response.
Starting on day 9, (group III) biological processes af-
fected included activation of anemia, inflammation of
the body, and inhibition of B cell activation and lipid
metabolism. Towards the end of the study at day 25
(group IV), new biological processes affected included
activation of protein translation and inhibition of differ-
entiation of lymphocytes. At day 30 (group V) biological
processes involving activation of lymphoid cancer and
inhibition of NK cell development were included. Fur-
ther details are described in the legend for Fig. 3 and
listed in the table in Additional file 4.
Quantitative PCR validation of selected genes
We validated the relative expression of two genes se-
lected on the basis of expression changes and consistent
patterns of change across the study. One gene, metallo-
thionein 2 (Mt2), was up regulated across the study and
the other, unc-93 homolog B1 (Unc93b1), was down
BA
Fig. 2 Summary of microarray gene expression results in blood cells after 90Sr injection. a Venn diagram of differentially expressed genes at
each time point showing numbers of genes overlapping between time points (the Venn diagram was generated using the online tool at
bioinformatics.psb.ugent.be/webtools/Venn/). There were 1184 genes that were common to all time points. b Heatmap of expression of the
1184 genes common across the study revealed that the majority of genes (1180 out of 1184) were down regulated rapidly after 90Sr injection,
and stayed repressed throughout the study
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regulated. As shown in Fig. 4a and b, the microarray and
qRT-PCR measurements were consistent at all times
measured although qRT-PCR measurements indicated
bigger changes than the microarrays. As all gene expres-
sion changes detected and used for analysis in this study
were robust (false discovery rate <0.002, and fold change
cut off ±2), extensive validation of gene expression was
not performed.
Pathway analysis and upstream regulation
We visualized gene expression in networks based on bio-
logical relationships using IPA Core analysis and the IPA
Comparison Tool, which groups biological processes and
pathways by significance and maximum connectivity be-
tween genes and regulators. We used the Upstream
Regulator Analysis Tool in IPA to predict potential mecha-
nisms and pathways and look for trends in the gene expres-
sion changes. We used the default z-score >2 or z-score <
−2 as the significance cutoff for our analyses. We looked
for predictions of activity of upstream regulators that were
consistent at all times, and also for those that might be
switched on and off at different points in the study.
Initially we limited the analysis to transcriptional regu-
lators and found that a large number of transcription
factors were predicted to be affected across the study.
This was consistent with the large number of differen-
tially expressed genes at each time point in our study,
which suggested that multiple regulators were likely to
be involved in the changing patterns of gene expression.
The top candidate regulators of transcription significantly
Fig. 3 IPA based enrichment of biological functions; the heatmap shows the top scoring biological functions across the study. Each column
indicates z-scores corresponding to enriched biological terms for the set of differentially expressed genes at the time indicated after 90Sr injection.
Columns were sorted by significant processes from early (day 4, group I) to late (day 30, group V), in the study. Group I included processes that
were affected across the study. Group II processes were affected starting on day 7; Group III processes, on day 9; Group IV, started at day 25, and
Group V were significant only at day 30 in the study. The colors of the cells indicate z-scores, potentially activated/promoted processes (varying
shades of orange) and potentially inhibited/suppressed processes (varying shades of blue); in each case increasing darkness of color represents
increasing significance. Processes that did not appear in the core analysis result are shown in gray. The complete table with scores is in Additional
file 4
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predicted to be activated at four or more times were
Trim24, Nkx2-3 and Bcl6. Transcriptional regulators Gfi1,
Nupr1, Stat6, Elf4, Satb1 and E2f4 were predicted to be acti-
vated at 3 or more time points in the study. The top predic-
tions for inhibition of transcriptional regulators were Irf7,
Myc, Xbp1, Irf1, Stat1, E2f1 and NFκB, all of which have
been implicated in cellular stress responses. These results
are summarized in Fig. 5a; the heat map shows all transcrip-
tion factors that were predicted to be affected at various
time points in the study, based on gene expression changes.
Additionally, we also looked for the predicted status of up-
stream regulators categorized as cytokines, G-protein recep-
tors, ligand-dependent nuclear receptors, transmembrane
receptors, kinases and phosphatases, and found that many
members of the Interferon family of proteins (Ifna1, Ifna2,
Ifnb1, Ifnar and Ifnz) were predicted to be inhibited at day
4, Fig. 5b (The complete table with z-scores is in Additional
file 5). Members of the Interleukin family of cytokines (Il2,
Il3, Il4, Il5, Il6, Il7, Il12, Il15 and Il27) were also predicted to
be inhibited between day 4 and day 9. Cd3 (Cluster of differ-
entiation 3 and member of the T-cell receptor complex);
Cd28 (Cluster of differentiation 28 and stimulator of T-cell
differentiation); Mapk4 (mitogen-activated protein kinase
kinase kinase kinase 4) regulators, known to be involved in
TNFα signaling; and Ptger4 (prostaglandin E receptor 4
(subtype EP4), receptor for binding prostaglandin E2) were
top candidates for activation in this study.
We also looked for those transcriptional regulators that
may be switched on and off or vice versa at specific times in
the study and found that some transcriptional regulators
may be only significantly involved at one time or another
and at other times silent. We found none that changed the
direction of their activity during the course of the study.
Interestingly, although the largest number of genes were dif-
ferentially expressed at day 30 (5768 genes), the predictions
suggested that there were more upstream regulators involved
at other times compared with day 30. Between days 4 and 9,
NFκB transcription factor dimer protein RelA was predicted
to be inhibited, and in addition to other members of the
NFκB family (NFkB1 inhibited at days 4 and 7) indicate that
this radiation response transcription factor may be muted in
blood cells.
We also used IPA upstream regulator analysis to investi-
gate potential miRNA activation. We found a number of
miRNA that were predicted to be activated in the study
with z-scores >2 across all time points, whereas others were
only predicted to be activated at one time point, Fig. 6a. Of
the 24 miRNA shown here, mmu-miR-16, mmu-miR-124,
mmu-miR-125 and mmu-miR-210 were selected for investi-
gation and RNA levels were measured using qRT-PCR, the
result is shown in Fig. 6b (The complete table with z-scores
is in Additional file 6). All microRNA tested were observed
to be up regulated at day 4, with a decrease to background
levels between days 7 and 9, followed by another induction
peak at day 25 in the study.
Discussion
Radioisotopes as internal emitters have been studied for
their effects on human tissues and organs, used as
tracers and investigated for their detrimental effects on
humans after nuclear accidents. Exposure to 90Sr as an
internal emitter is usually in the context of an accident
where exposure is combined with other radionuclides,
such as 137Cs and 131I [8]; and external radiation from
atmosphere, soil and through contact. This makes it dif-
ficult to identify changes that may be the result of a sin-
gle emitter and its possible effect on human health.
Studies that have attempted to address these issues
using animal models have used simple combinations of
radioisotopes and one or more mode of delivery to
examine the long-term effects of chronic exposure to
internal emitters. In this study, 90Sr was injected intra-
venously. Using this mode of administration, we were
dealing only with uncertainties related to the activity
measurement as well as to the ones related to the sys-
temic distribution and retention. We used only one










































Fig. 4 qPCR validation of microarray results for Mt2 a and Unc93b1 b, these genes were selected as representatives of consistently up (Mt2) and
down (Unc93b1) regulated genes in the study. Relative gene expression measurements by qRT-PCR showed the same pattern of expression as
the microarray results. Points are average of 6 samples per condition
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Fig. 5 (See legend on next page.)
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injection dose, so comparison of different dose-rates at
similar time points were not compared in this study.
A previously published study from our group, in which
137Cs was injected into mice and gene expression of
blood investigated over a 30-day period, showed that a
large number of genes were affected by this internal
emitter [24]. The final dose in this study was 9.9 Gy at
30 days, and resulted in thousands of genes differentially
expressed, with many affected biological functions found
to be in common with the present 90Sr study. Because of
Cesium’s biokinetic properties, dose rates in the 137Cs
study were quite variable, ranging from an average of
1 Gy/day at the beginning of the study to 0.04 Gy/day
between days 20 and 30. In contrast, 90Sr injection pro-
duced a more even low dose rate that ranged between
an average of 0.3 Gy/day at the beginning of the study
and 0.1 Gy/day between days 25 and 30. Many biological
function terms were in common between the genes
affected in blood by both 90Sr and 137Cs, however the
prominent switch of genes belonging to the same
(See figure on previous page.)
Fig. 5 IPA-predicted upstream regulators of gene expression. a Heatmap of predicted activation and inhibition states of transcription regulators
that may be upstream of gene expression changes seen in the study. b Upstream regulators categorized in IPA as cytokines, transmembrane and
nuclear receptors, kinases and phosphatases. In both heat maps, colors indicate z-scores, shades of blue represent inhibition of the regulator, and
shades of orange represent activation of the regulator and missing values are in gray (missing values are shown where the regulator did not have
any known relationship with the significantly changed genes at that time). We used the default cut off z-score >2 or < −2 as significant for our
analyses, although, z-scores between −2 and 2 are shown in the figures. The complete table with z-scores is in Additional file 5
A B
Fig. 6 MicroRNA upstream regulators of gene expression. a Heatmap of predicted activation states of microRNA, which may be upstream of
gene expression changes observed in the study (shades of orange, positive z-scores; missing values in gray, missing values are shown where the
regulator did not have any known relationship with the significantly changed genes at that time). b qPCR validation of selected miRNA species:
mmu-miR-16 (⨂), mmu-miR-124 (□), mmu-miR-125 (♦) and mmu-miR-210 (●). Expression peaked at the day 4 time point as predicted from the
mRNA data. The complete table with z-scores is in Additional file 6. Each point is the average of 4 samples per condition
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biological process from up to down that was seen in the
137Cs study was not observed after 90Sr injection. The
differences in gene expression response to 90Sr and
137Cs could be due to localization of the radioisotopes to
different regions within the mouse body, to the different
radiation quality of γ-rays and β-particles, and also to
the different dose-rate gradients generated by the two
isotopes after injection [24].
In another study, mice were injected with 131I, in
which the absorbed dose was 0.1-9.7 mGy over a 24 h
period, with the highest absorbed dose in the lung,
which consequently had the largest number of differen-
tially expressed genes [5]. The lowest average dose rate
in the present 90Sr study was 100 mGy/day, a factor of
10 higher than the highest dose rate in the 131I study,
and although different tissues were assessed for gene
expression changes in the 131I study (lung, liver, kidney
and spleen) there was an overall suppression of immune
response in these animals, also seen in our results in
blood.
Injection of 90Sr into C57BL/6 mice in our study did
not have an effect on overall animal health and activity
levels within the 30-day study. However, there was a dra-
matic effect on gene expression, starting at the earliest
time measured with a relatively high number of genes
changing, 3957 at day 4 (Table 1). The number of genes
affected increased to 5768 genes at day 30 with at least
50 % of genes overlapping between successive time
points, implying that the effect of 90Sr was significant
throughout the study despite the lower dose rate at later
times. The number of genes in common between all the
time points measured was 1184, in contrast to the result
from the previous 137Cs study, in which only 5 genes
were significantly differentially expressed at all the time
points measured [24]. Taken together, this suggests a
strong dose-rate effect on gene expression, in addition
to the effect from accrued dose. Dose-rate effects may
be especially prominent in an in vivo model, such as
mouse, where blood cells may repopulate to give rise to
secondary waves of biological responses. Additionally,
90Sr localized to the bone, potentially affecting hema-
topoietic functions more strongly relative to other whole
body effects as observed in the 137Cs study.
Functional analyses of all gene expression across the
study revealed processes mostly related to immune re-
sponses, activation of apoptosis of B and T cells, changes
in growth of spleen, and defects in response to infection
(Fig. 3). These were the main biological changes, sup-
ported by enrichment of genes belonging to specific
immune pathways that were in the 1184 genes common
to all time points. Pathway terms appearing in gene
ontology analysis of the 1184 common genes, comprised
of the B-cell receptor signaling pathway, which results in
the expression of genes that further activate the
expression of other genes involved in B cell proliferation,
differentiation and Ig production [31]. The second path-
way involving IgA production is part of the first line of
defense against microbial infection. IgA is a non-
inflammatory antibody produced by an IgA plasma cell
[32] and the overall repression of this pathway could
indicate a reduction in the ability of the animal to
neutralize toxins and pathogenic microbes. The third
pathway listed includes genes involved in RNA degrad-
ation pathways that monitor the quality and turnover of
RNA in cells, in order for correct protein translation to
occur [33]. These processes may be compromised in
blood cells after exposure to 90Sr, leading to further de-
fects in biological functions involving many proteins. The
fourth pathway involved primary immunodeficiency that
affects cellular and humoral immunity and may be per-
turbed due to defective cell maturation and function
during hematopoiesis [34], which could be compromised
after 90Sr injection and deposition of the radioisotope to
bone. RNA degradation pathways, also indicated to be
significantly affected across the study may potentially
have a widespread effect on integrity of messenger RNA
of blood cells, and defective monitoring and removal of
missense mRNA may result in the production of dysfunc-
tional proteins in cells. The large proportions of down
regulated genes in this study suggest that 90Sr localization
in the proximity of the hematopoietic compartment may
have compromised the development of certain subsets of
the blood cells. Further investigations will be needed to
confirm this.
The impact of 90Sr injection on gene expression was
also analyzed using a prediction algorithm for upstream
regulators in IPA (Fig. 5a and b). Initially we limited
predictions to transcriptional regulators that recognize
promoters of other genes or have a direct effect on
known transcriptional factors. The top activated regula-
tors predicted were Trim24, Gfi1, Nupr1 and Nkx2.3.
The Trim24 (tripartite motif-containing 24) protein
functions as an E3 ubiquitin ligase for p53 and may lead
to the termination of the DNA damage response medi-
ated by p53 [35, 36]. There is evidence that Trim24-/-
mutant mice show adverse effects of calcium metabolism
and deposition in arterioles [37] and Trim 24 activation
as predicted in our study may be related to altered con-
centrations of strontium and calcium in the mouse. Gfi1
(growth factor independent 1) protein transcriptional
factor is a known inhibitor of the p53-dependent DNA
damage response in the progress of leukemia [38] and
also has an important role in erythroid cell lineage de-
velopment [39]. Activation of Gfi1 may be characteristic
of activation of specific hematopoietic progenitor cells in
response to 90Sr [40]. Both Trim24 and Gfi1 have known
effects on p53 function in cells, leading to defects in
growth and development. Another top predicted activated
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regulator of gene expression was Nkx2.3 (NK2 homeobox
3) protein, which is a homeodomain protein with an im-
portant role in the maintenance of the structure of the
spleen [40]. It is required for proper growth of spleen
fibroblast cells and may affect complement factor aggrega-
tion and immune function of the organ [41]. Activation of
Nkx2.3 may indicate changes in levels of spleen growth
and contribute to the changes in blood gene expression as
a result of these changes.
The p53 transcription factor, although not meeting the
criteria for inclusion in Fig. 5a, was predicted to be
inhibited across the study (IPA generated z-scores for
p53 effect on gene expression were −1.3, −2.4, −2.1 and
−1.8; at days 4, 7, 9 and 30, respectively). In our 137Cs
study, this central radiation response factor and many of
its downstream effector genes were activated at early
times, and then inhibited at later times [24], giving a
precedent for inhibition of p53 by internal radiation
emitters.
We next looked specifically for gene expression changes
of known radiation genes after 90Sr injection and found
that mRNA for Cdkn1a (cyclin-dependent kinase inhibitor
1a), Ccng1 (Cyclin G1), Ddb2 (damage-specific DNA bind-
ing protein 2) and Bbc3 (BCL2 binding component 3)
were significantly affected at some times in the microarray
data. We used quantitative RT-PCR to validate the
changes in gene expression for these p53 targets and the
result is shown in Fig. 7; in panel a, Cdkn1a and Ccng1
transcripts were induced early and then between days 7
and 25 appeared to stabilize at a level slightly higher than
controls. Panel b shows transcriptional changes in Ddb2
and Bbc3 genes, which were also induced at higher levels
at day 4 but then repressed by day 9, after which they were
repressed even further by day 30.
Upstream regulators of gene expression that were
strongly predicted to be inhibited across the study were
Irf7, Myc and Xbp1. Irf7 or Interferon regulatory factor
7, is a transcriptional factor produced in response to
viral infections, and the regulation of Irf7 is strongly
controlled because of effects on auto-immunity and
cancer [41]. The predicted inhibition of Irf7 after 90Sr in-
jection may indicate a reduced ability to respond to
infections as reflected by changes in transcriptional tar-
gets of this protein. Xbp1, X-box binding protein 1, also
predicted to be inhibited in this study, is a known regu-
lator of MHC (major histocompatibility complex) class
II molecule expression in B-cells [42]. This may have an
effect on the development of B-cells in vivo, which is
also known to occur in response to long-term 90Sr
exposure in humans [43].
The heat map in Fig. 5b, shows the predicted states of
upstream regulators of gene expression that were not
categorized as transcription factors or direct repressors
of transcription factors, and included G-protein recep-
tors, ligand-mediated and transmembrane receptor pro-
teins, kinases and phosphatase types of molecules. Of
these factors, most predictions were of inhibition at day
4. An overview of the types of molecules in this list re-
vealed that the Interferon protein family was the most
prominent protein type, members of which were pre-
dicted to be inhibited at day 4 through day 9. The sec-
ond most prominent group was the Interleukin protein
family, also with a similar pattern of inhibition but more
widespread across all times. Inhibition of Interferons
may indicate defects in the hematopoietic capacity of
quiescent stem cells, as studied in response to infection
[44] but also possibly in response to exposure to radi-
ation from 90Sr.
One of the most interesting observations in this study
was that the majority of significantly differentially ex-
pressed genes at all time-points were down regulated,
ranging from 91 % of all genes at day4, to 77 % of all genes
A B
Fig. 7 Radiation related gene expression. a Genes such as cyclin dependent kinase inhibitor 1 a, Cdkn1a (♦) and CyclinG1, Ccng1 (■), were
consistently induced across most of the time course. b Transcript levels for the genes Damage specific DNA binding protein, Ddb2 (⊠) and Bcl2
binding component 3 protein, Bbc3 (⨂), were initially induced, then back to control levels by day 9, and then stayed mostly repressed until day
30. Each point is the average of 3 samples per condition
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at days 25 and 30 (Table 1). Additionally, there were 1180
genes common to all time points that were down regu-
lated to similar levels across the entire study, representing
an average of 33 % of the total genes affected at each time.
The large number of down regulated genes and the
consistent, dose-independent, changes observed at all
times (Fig. 2b), suggested a possible role for microRNA-
mediated repression of genes, potentially acting to sup-
press gene expression in a highly concerted manner [45],
see also Additional file 7, which includes a network show-
ing the microRNA and their potential target mRNA and
the overlap of these networks. We selected microRNA for
further testing on the basis of the strength of the predic-
tion (z-score) and also the number of potential targets for
that microRNA as predicted in IPA. We measured the
transcript levels of mmu-miR-16, mmu-miR-124, mmu-
miR-125 and mmu-miR-210 and observed the early induc-
tion of all four microRNA, consistent with their predicted
state at that time, Fig. 6a and b. Between days 7 and 9, the
levels of these microRNA species were seen to fall, with a
slight increase again at day 25. The dynamics of micro-
RNA induction shown here, suggest a role in early repres-
sion of target genes followed by maintenance of low target
mRNA levels, however further studies are required to
determine the exact role and mechanism of microRNA
effects on gene regulation after 90Sr exposure [46, 47].
MicroRNA are known to be characteristically expressed in
certain blood cell sub-sets and mmu-miR-125 is highly
expressed in T cells and neutrophils in blood [48]. Micro-
RNA are also known to respond to external radiation, in
different cell types and also in vivo in blood [49–52],
therefore the microRNA measured in this study may be
strong candidates for further investigation for modulation
of gene expression as a result of exposure to 90Sr. This is
the first report of an effect of radiation exposure from an
internal emitter on microRNA gene expression in blood.
Conclusion
We showed that the radionuclide 90Sr, when injected into
mice was rapidly localized to skeleton, and led to a dra-
matic effect on gene expression in mouse blood cells. In
the course of our 30-day study, a total of 8082 genes were
changed, with the majority of genes being down regulated.
Pathways that were affected at all times in the study
belonged to immune functions related to B-cell develop-
ment and RNA maintenance, indicating that 90Sr had a
long-lasting and widespread effect on blood cell devel-
opment and also housekeeping processes in the cells.
Application of prediction algorithms identified potential
regulators of gene expression and suggested a possible
role for microRNA-mediated gene regulation in re-
sponse to this internal emitter. 90Sr, as an internal
emitter was able to elicit a distinct response in mouse
blood cells, with a large number of genes being down
regulated and staying repressed throughout the study,
which was very different from the response to 137Cs in
blood. Differences in transcriptomic response may lead
to identification of separate radionuclide-specific biodo-
simetry signatures and also impact the type of diagnosis
and treatment after exposure.
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